| NCT05531656 | A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-06-28 | 2027-04 | 2027-04 |
| NCT05893537 | Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD). | TERMINATED | PHASE2 | 2023-06-16 | 2025-03-28 | 2025-03-04 |
| NCT05225415 | Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies | COMPLETED | PHASE2 | 2022-05-19 | 2024-11-25 | 2024-11-25 |
| NCT05248672 | Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers | COMPLETED | PHASE1 | 2022-02-15 | 2022-06-01 | 2022-06-01 |
| NCT05225389 | Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects | COMPLETED | PHASE1 | 2021-12-31 | 2022-01-24 | 2022-01-17 |
| NCT04735536 | Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG | COMPLETED | PHASE2 | 2020-07-09 | 2023-04-26 | 2023-04-26 |
| NCT03507790 | A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. | COMPLETED | PHASE2 | 2018-10-10 | 2024-05-29 | 2024-05-29 |
| NCT03522129 | Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE1 | 2018-05-30 | 2019-02-06 | 2019-02-06 |
| NCT03493282 | Effect of CT1812 Treatment on Brain Synaptic Density | COMPLETED | PHASE1, PHASE2 | 2018-03-28 | 2020-10-16 | 2020-10-16 |
| NCT03716427 | Drug Interaction Study of CT1812 in Healthy Volunteers | COMPLETED | PHASE1 | 2016-11-10 | 2017-02-15 | 2016-12-27 |
| NCT02907567 | Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE1, PHASE2 | 2016-09 | 2017-09 | 2017-08-24 |
| NCT02570997 | Ascending Dose Study of CT1812 in Healthy Volunteers | COMPLETED | PHASE1 | 2015-09 | | 2016-05 |
| NCT00529581 | A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis | COMPLETED | PHASE2 | 2006-11 | 2008-04 | 2008-03 |